RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligand.
Zhan
Y
Y
Johns Hopkins University School of Medicine, Department of Radiology, Baltimore, Maryland 21205, USA.
Saindane
A M
AM
Scheffel
U
U
Carroll
F I
FI
Holmquist
C R
CR
Kepler
J A
JA
Taylor
G F
GF
Kuhar
M J
MJ
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism*; D003042:Cocaine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D003891:Desipramine / Q000494:pharmacology; D050483:Dopamine Plasma Membrane Transport Proteins; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D007700:Kinetics; D008024:Ligands; D008297:Male; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D051379:Mice; D009419:Nerve Tissue Proteins; D009928:Organ Specificity; D017374:Paroxetine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D014316:Tritium
D002352:Carrier Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D018765:Dopamine Uptake Inhibitors; D008024:Ligands; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D010879:Piperazines; C106789:RTI 352; D014316:Tritium; D017374:Paroxetine; C069723:2beta-carbomethoxy-3beta-(4-iodophenyl)tropane; C043425:vanoxerine; D003042:Cocaine; D003891:Desipramine